International Congress on the Future of Breast Cancer® East
July 17 - July 18
The 19th Annual International Congress on the Future of Breast Cancer® East will update clinicians on recent advances in the treatment of breast cancer, from breakthroughs in the lab to changes in treatment paradigms, focusing on the practical implications of emerging data for patient care in the clinic. Novel agents and improved regimens, coupled with more accurate molecular and phenotypic subtyping, are driving the future of breast cancer therapy. Recent data and their clinical impact are highlighted throughout the program, in the context of optimally individualizing breast cancer therapy. Current areas of controversy or uncertainty will also be debated, with discussion of ongoing clinical trials and investigational approaches designed to address these questions. This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in the field of breast cancer in order to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.